Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.
about
A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectantsA2 gene of Old World cutaneous Leishmania is a single highly conserved functional gene.A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections.Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern FranceHIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania.Visceral leishmaniasis and HIV coinfection in the Mediterranean region.Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms.The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysisVisceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patientsNew challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.Epidemiology of leishmaniasis in Spain based on hospitalization records (1997-2008).HIV and the transmission of Leishmania.Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.The biological diagnosis of leishmaniasis in HIV-infected patients.The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV.Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review.A century of leishmaniasis in Alpes-Maritimes, France.Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.Leishmaniasis: new insights from an old and neglected disease.Case study of a patient with HIV-AIDS and visceral leishmaniasis co-infection in multiple episodes.Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients.Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients.Diagnosis of visceral leishmaniasis: the sensitivities and specificities of traditional methods and a nested PCR assay.
P2860
Q24800614-29B63CAF-444A-4BAC-ABE4-960530F40F49Q24811684-5AA9B0EE-B926-48B7-935F-4757D60F6618Q28541690-DABF1608-A899-44A1-8E45-D85108E8826BQ30833358-E1F7D2BE-A43F-42E1-B924-ABCD871B0098Q31029820-10C04D5B-5B92-40CD-818D-DDA22994EB41Q33961002-83C7FAF4-BE91-415C-B6D4-C2D550BD9F23Q34069486-AA25BE13-744E-4B7E-9DB8-A39BEA53B741Q34075119-89854EB5-1336-4497-9EE0-8266604476BCQ34128568-86108550-4EA7-4A06-A72A-E1F619C1EAC5Q34284119-81495206-FF06-4A15-821F-33FD392C2E9DQ34293034-C5A01D36-D196-4C22-918B-7D71244A1B7EQ34437935-708E198D-B23D-40E6-9E25-ABA0F25F0172Q35219247-22D1CFE1-3634-47BA-BCE0-EF57D403FE1CQ35494367-54F3B92F-C047-4365-B52F-C761375AB9A8Q35609024-165D5902-FDEC-4458-935D-1B655E3BE1FBQ35609037-02773E39-9F4E-41BB-A58C-5AEC4B20B6B9Q35609045-435EEF1C-66DA-4AD5-BB96-0DF58E37D9ADQ35609056-33A02872-883E-4B6E-B34B-36708FE250BDQ36328956-3D7FBFD4-7980-4D7E-AD81-C14A153C06AAQ36733559-6ED44C1B-1D11-4442-BBA7-3D3244B0D68BQ36945202-6C550C95-A4DE-493C-BAFE-90AE4565FD1DQ37059020-DEAB4FE2-9DAA-4B37-A3EB-752652ADB383Q37870821-CD69C88A-B0D3-424A-9177-26E68C04621DQ40228738-41E007D8-B87B-4655-A443-BAAE1EFC4220Q44247986-B0A8C815-0C9A-45B6-8C23-2DFC09C547D8Q44733416-D82EBF0B-E981-4782-9D51-C595B9226C36Q45738692-29A722E1-3F96-4645-A103-4A22513E492EQ54695571-26E4F882-8CD8-4E1C-BAE4-C7484F67C75E
P2860
Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@en
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@nl
type
label
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@en
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@nl
prefLabel
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@en
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@nl
P2093
P1433
P1476
Visceral leishmaniosis in HIV- ...... the CD4+ T-lymphocyte counts.
@en
P2093
Caroli-Bosc C
Le Fichoux Y
Lelièvre A
Quaranta JF
Staccini P
P304
P356
10.1097/00002030-199816000-00009
P407
P577
1998-11-01T00:00:00Z